Deflazacort oral suspension 6 mg/5 ml

Deflazacort is a corticosteroid prodrug with an active metabolite, 21-deflazacort, which binds to the glucocorticoid receptor to exert anti-inflammatory and immunosuppressive effects on the body.1,9,10 The exact mechanism by which deflazacort exerts its therapeutic effects in patients with DMD is unknown but likely occurs via its anti-inflammatory activities

Treatment of cancer, Treatment of Inflammatory conditions, Treatment of Autoimmune conditions, Treatment of Duchenne muscular dystrophy(DMD)

Deflazacort oral suspension 6 mg / 5 mln belongs to a group of medicines known as corticosteroids. Its anti-inflammatory and immunosuppressive properties give it the ability to treat a wide range of conditions in children. It is also one of the primary medicines used for Duchenne muscular dystrophy in infants and children.